Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review
Cells · 26.03.2025 · 14 (7) · 493
DOI: 10.3390/cells14070493 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cells, online erschienen am 26.03.2025. Verfasst von Balu Usha Rani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Disruption and Reproductive Toxicology Laboratory (EDART), Department of Biotechnology, School of Bioengineering, SRM Institute of Science …. Hauptthemen laut MEDLINE: Endocrine Disruptors, Epigenesis, Genetic, Pre-Eclampsia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Preeclampsia (PE) is a critical complication of pregnancy that affects 3% to 5% of all pregnancies and has been linked to aberrant placentation, causing severe maternal and fetal illness and death.
Objectives
This systematic review aims to elucidate the association of in-utero endocrine-disrupting chemical (EDC) exposure and microRNAs and their imprinted genes from prenatal and maternal circulation of PE patients.
Methods
Databases such as PubMed, PubMed Central, ScienceDirect, the Comparative Toxicogenomics Database (CTD), ProQuest, EBSCOhost, and Google Scholar were utilized to search for articles that investigate the relationships between selected EDCs and epigenetic events such as DNA methylation and microRNAs that are associated with PE.
Results
A total of 29 studies were included in the database search. Altered expression of microRNAs (miR-15a-5p, miR-142-3p, and miR-185) in the placenta of PE patients was positively associated with the urinary concentration of phthalates and phenols in the development of the disease in the first trimester. EDCs such as phenols, phthalates, perfluoroalkyl substances (PFOAs), polybrominated diphenyl ethers (PBDEs), and organochlorine phosphates (OCPs) have been reported to be associated with hypertensive disorders in pregnancy. miRNA-31, miRNA-144, miRNA-145, miRNA-210, placental specific clusters (C14MC, and C19MC) may be used as possible targets for PE because of their potential roles in the onset and progression of PE.
Conclusions
Prenatal EDC exposure, including exposure to BPA, showed association with signaling pathways including estrogen, sFlt-1/PlGF, ErbB, MAPK/ERK, and cholesterol mechanisms with placental hemodynamics. Even low EDC exposures leave altered epigenetic marks throughout gestation, which might cause PE complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Disruption and Reproductive Toxicology Laboratory (EDART), Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, India.
- Toxicology Research on Endocrine Disruptors (TRENDS) Laboratory, PG & Research Department of Advanced Zoology and Biotechnology, Government Arts College, Nandanam, Chennai 600035, India.
- Department of Critical Care Medicine, SRM Medical College Hospital & Research Centre, SRM Institute of Science and Technology, Kattankulathur 603203, India.
ORCID-Profile: Balu Usha Rani, Ramasamy Vasantharekha, Winkins Santosh, Seetharaman Barathi
Zitieren
APA
Rani, B. U., Vasantharekha, R., Santosh, W., Swarnalingam, T., & Barathi, S. (2025). Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review. Cells, 14(7), 493. https://doi.org/10.3390/cells14070493
Vancouver
Rani BU, Vasantharekha R, Santosh W, Swarnalingam T, Barathi S. Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review. Cells. 2025;14(7):493. doi:10.3390/cells14070493
BibTeX
@article{Rani2025,
author = {Rani, Balu Usha and Vasantharekha, Ramasamy and Santosh, Winkins and Swarnalingam, Thangavelu and Barathi, Seetharaman},
title = {Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review},
journal = {Cells},
year = {2025},
volume = {14},
number = {7},
pages = {493},
doi = {10.3390/cells14070493}
}
EUVIMED